It is call p*mp and du*p.
They p*mp through this equity firm with unrealistic price target of $45. $45 would put ambs, with all shares converted, to market value close to a billion dollar..People are buying in the hype.. How realistic is that, yet they dont have anything in phase III trial. I expected lympro to carry them over financially, it has not materialzed. So they will need retail investors to carry AMBS over with more shares on the market. This huge rating is just to allow for more d*mp. They have filed lately to dilute as many as 10 millions shares. YOu have to create the demand to absorb all those shares, if not the pps will go to oblivion.
10 millions shares, almost double the O/S, that is not small, just to pay down debt.
Therefore, I believe another round of financing will be needed to fund the pipeline and pay bills and salaries, inevitable. Once the dust settles then the pps will take off like a rocket. Not untill then, IMO
Patience is virtue